Canadian Center for Vaccinology, IWK Health Centre and Dalhousie University, Halifax, NS.
Can J Public Health. 2010 Jan-Feb;101(1):12-4. doi: 10.1007/BF03405553.
Since routine meningococcal C conjugate vaccination was introduced into Canada in 2002, there have been a large regional variation in the routine programs, changes to the timing of the infant series in some provinces, and wide differences in catch-up programs. As immunization is viewed as a provincial responsibility, less attention has been paid to determining national coverage rates and the direct and indirect effects of the widely varying provincial/territorial vaccination programs on the nation as a whole. Canada's disjointed regional immunization campaigns leave the population at risk of disease for an extended length of time. The United Kingdom has proven that with a pro-active approach to planning, coordination, and implementation of a national immunization program, excellent long-term control of invasive meningococcal disease in a large population could be achieved in as little as one year. A summation of the current meningococcal immunization strategies used in Canada and an estimate of overall vaccine coverage of children and youth is provided.
自 2002 年加拿大常规接种脑膜炎球菌 C 结合疫苗以来，常规方案在地区间存在较大差异，一些省份调整了婴儿系列疫苗的接种时间，且补种计划也存在很大差异。由于免疫接种被视为省级责任，因此对确定全国覆盖率以及各省/地区接种计划对整个国家的直接和间接影响的关注度较低。加拿大支离破碎的区域免疫运动使民众面临疾病的风险时间延长。英国已经证明，通过积极主动的方法规划、协调和实施国家免疫计划，可以在短短一年内实现对大量人群侵袭性脑膜炎球菌病的长期有效控制。本文总结了加拿大目前使用的脑膜炎球菌免疫策略，并估计了儿童和青少年的总体疫苗覆盖率。
